Rebecca Ladd Kilpatrick, PhD

Dr. Amanda Gilmore received her Ph.D. in clinical psychology from the University of Washington in 2015. She completed her clinical internship training at the VA Puget Sound Health Care System, Seattle Division and her postdoctoral training in child and adult trauma research at the National Crime Victims Research & Treatment Center (NCVC) at MUSC. She joined the MUSC faculty in 2016 and currently holds a joint appointment in the College of Nursing and the Department of Psychiatry & Behavioral Sciences as a research assistant professor. Dr. Gilmore is a licensed clinical psychologist and sees patients at Comprehensive Psychiatric Care Specialists. Her clinical work focuses on the use of cognitive-behavioral therapies for post traumatic stress disorder, substance use disorders, anxiety disorders, depressive disorders, and sexual dysfunction. Dr. Gilmore was trained by Dr. Marsha Linehan, the treatment developer of DBT and has served as a consultant for implementing DBT in community mental health and conducts DBT training for community mental health professionals.

Lillian M Christon, PhD is a highly experienced psychologist specializing in psychiatry and bio-behavioral medicine in Charleston, SC. With a focus on coping with chronic medical and psychiatric conditions, Dr. Christon offers a range of therapeutic approaches including acceptance and commitment therapy, cognitive behavioral therapy, and stress management. As a trusted provider, Dr. Christon is dedicated to helping patients adapt to medical illness and disability, providing psychotherapy and support for individuals facing various challenges. With a strong emphasis on positive psychology, her expertise in behavioral medicine contributes to the overall well-being of her patients.Generated from the website

Dr. Jennifer Dahne received her Ph.D. in Clinical Psychology from the University of Maryland, College Park in 2016. She completed her predoctoral internship at the Medical University of South Carolina/Ralph H. Johnson VA Medical Center and her postdoctoral fellowship via MUSC's National Institute on Drug Abuse (NIDA) T32 training program. Dr. Dahne subsequently joined the MUSC faculty in 2018 and she is currently an Associate Professor, affiliated both with the Addiction Sciences Division of the Department of Psychiatry and with the Hollings Cancer Center, Cancer Control Program. The overarching goal of Dr. Dahne's research program is to significantly reduce the public health impact of tobacco use, with a specific focus on cigarette smoking among vulnerable populations (e.g. socioeconomically disadvantaged adults, individuals with additional physical and mental health comorbidities). The majority of Dr. Dahne's work centers around development and evaluation of technology-based remote interventions for the treatment of smoking cessation and common comorbidities (e.g. depression). Dr. Dahne also currently serves as Co-Director of MUSC's Remote & Virtual Trials Program and has interests in developing methods to improve the feasibility and rigor of remote trials. Dr. Dahne is a current NIDA K23 recipient and is also PI of a NIDA-funded R41, a National Cancer Institute-funded R21, and a National Institute of Mental Health-funded R42. She is also an active collaborator on several NIH-funded projects focused on smoking cessation and telehealth intervention delivery.